Related Experiment Videos
Immunodetection of gastrin-releasing peptide in malignant melanoma cells
K N Charitopoulos1, A C Lazaris, K Aroni
1Department of Pathology, The Athens National University Medical School, Greece.
Abstract:
Gastrin-releasing peptide (GRP), the mammalian counterpart of bombesin, was first identified in the nervous system of the gastrointestinal tract. Little is known about its distribution in the human skin or about its function in certain diseases such as malignant melanoma. Recently functional GRP receptors have been found on human melanoma cell lines. We therefore investigated, using immunohistochemistry, whether human melanoma cells express GRP and whether there is a significant change in its distribution among the different clinical types of melanoma and a connection to histopathological features such as growth phase, type of malignant cells, Breslow thickness and Clark level of invasion. We demonstrated the existence of GRP in all clinicopathological types of melanoma; a predilection for quantitatively increased GRP immunostaining was noticed in nodular melanomas (P = 0.007). As well as this, we observed a restriction of GRP expression at a specific level of invasion, i.e. within the reticular dermis (Clark IV) (P = 0.032). GRP immunoreactivity was found to be associated with an increased amount of melanin pigment in malignant cells (P = 0.054). The presence of GRP in malignant melanocytes, along with its association with the various histopathological features, suggests that GRP may play a role in the pathophysiology of this type of cutaneous tumour.
Insights
Gastrin-releasing peptide (GRP) is present in all melanoma types. Increased GRP was found in nodular melanomas and linked to deeper invasion and higher melanin content, suggesting a role in melanoma development.
Area of Science:
- Oncology
- Dermatology
- Molecular Biology
Background:
- Gastrin-releasing peptide (GRP), the mammalian bombesin analog, is primarily known for its role in the nervous system.
- Its presence and function in human skin, particularly in malignant melanoma, remain largely uncharacterized.
- Functional GRP receptors have recently been identified on human melanoma cell lines.
Purpose of the Study:
- To investigate the expression and distribution of GRP in various human melanoma types.
- To correlate GRP expression with key histopathological features of melanoma.
- To explore the potential role of GRP in melanoma pathophysiology.
Main Methods:
- Immunohistochemistry was employed to detect GRP expression in human melanoma tissues.
- GRP immunostaining was quantified and analyzed.
- Statistical analysis was performed to assess associations between GRP levels and clinicopathological parameters.
Main Results:
- GRP was detected in all clinicopathological types of melanoma studied.
- Significantly increased GRP immunostaining was observed in nodular melanomas.
- GRP expression was associated with a specific invasion level (Clark IV) and increased melanin pigment within malignant cells.
Conclusions:
- Human melanoma cells express GRP.
- GRP expression correlates with specific melanoma subtypes and histopathological characteristics.
- These findings suggest GRP may contribute to the development and progression of cutaneous melanoma.